Maria-Gabriela Aniței

Grigore T. Popa University of Medicine and Pharmacy — Romania

Medicine · Health Sciences

7h-index717citations42works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Surgical Treatments(23), Cancer Immunotherapy and Biomarkers(21), Colorectal and Anal Carcinomas(20), Colorectal Cancer Treatments and Studies(6), Cancer Genomics and Diagnostics(5)

Publications42 total

Pathological Complete Response in Rectal Cancer Patients: A Correlation Between Pathological and Clinical Stage and Oncological Outcome
Cancers·2026Open Access
The Treatment of Pancreatic Neuroendocrine Tumors - A Retrospective Single-Centre Study
Chirurgia·2025· 1 citedOpen Access
Therapeutic Obstinacy in End-of-Life Care—A Perspective of Healthcare Professionals from Romania
Healthcare·2024· 7 citedOpen Access
Spiritual Care for Cancer Patients at the End-of-Life
Healthcare·2024· 2 citedOpen Access
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy
Journal of Clinical Oncology·2023· 39 citedOpen Access
Breast Sarcomas—How Different Are They from Breast Carcinomas? Clinical, Pathological, Imaging and Treatment Insights
Diagnostics·2023· 10 citedOpen Access
Data from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figure 2 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Data from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Figure 1 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Tables 1 - 5 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figure 2 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Tables 1 - 5 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figures from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Tables from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Figure 1 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Data from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Data from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Figures from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Tables from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Viorel Scripcariu(36), Franck Pagès(27), Florence Marliot(26), Amos Kirilovsky(26), Jérôme Galon(26), Guy Zeitoun(24), Nacilla Haicheur(23), Bernhard Mlecnik(22), Christine Lagorce(22), Dan Ferariu(16), Franck Zinzindohoué(16), Ana-Maria Todosi(15), Gabriela Bindea(15), Mihai Danciu(15), Patrick Bruneval(15), Jean‐Marc Chevallier(15), Anne Berger(15), Ana-Maria Mușină(14), Carine El Sissy(11), Marc Van den Eynde(10)